Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine
1. 675126-05-3
2. (1r,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine
3. (1r,4s)-trans-norsertraline
4. Norsertraline, (1r,4s)-trans-
5. Sep-225289
6. 4d28ey0l5t
7. Dasotraline [usan:inn]
8. Unii-4d28ey0l5t
9. Dasotraline [inn]
10. Dasotraline (usan/inn)
11. Dasotraline [usan]
12. Dasotraline [who-dd]
13. Schembl263142
14. Dasotraline(sep-225289)
15. Dasotraline; Sep 225289
16. Gtpl8308
17. Chembl3301595
18. Dtxsid20217855
19. Bcp24754
20. Ex-a2622
21. Zinc2510873
22. Dasotraline(sep-225289) Free Base
23. Db12305
24. Sep-225,289
25. Ac-36184
26. Hy-12850
27. Cs-0012724
28. D10700
29. A857937
30. Q27076989
31. (1r,4s)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-ylamine
32. 4beta-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalene-1alpha-amine
33. 1-naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-, (1r,4s)-
| Molecular Weight | 292.2 g/mol |
|---|---|
| Molecular Formula | C16H15Cl2N |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 291.0581549 g/mol |
| Monoisotopic Mass | 291.0581549 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 309 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Dasotraline has been shown in preclinical studies to be a potent and balanced reuptake inhibitor of serotonin, norepinephrine and dopamine (SNDRI). Serotonin, norepinephrine and dopamine are neurotransmitters associated with depression. There are currently no marketed treatments for depression that inhibit reuptake of all three neurotransmitters.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Dasotraline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dasotraline, including repackagers and relabelers. The FDA regulates Dasotraline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dasotraline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dasotraline supplier is an individual or a company that provides Dasotraline active pharmaceutical ingredient (API) or Dasotraline finished formulations upon request. The Dasotraline suppliers may include Dasotraline API manufacturers, exporters, distributors and traders.
Dasotraline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dasotraline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dasotraline GMP manufacturer or Dasotraline GMP API supplier for your needs.
A Dasotraline CoA (Certificate of Analysis) is a formal document that attests to Dasotraline's compliance with Dasotraline specifications and serves as a tool for batch-level quality control.
Dasotraline CoA mostly includes findings from lab analyses of a specific batch. For each Dasotraline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dasotraline may be tested according to a variety of international standards, such as European Pharmacopoeia (Dasotraline EP), Dasotraline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dasotraline USP).
LOOKING FOR A SUPPLIER?
